XOMA Price to Book Ratio 2006-2021 | XOMA

Historical price to book ratio values for XOMA (XOMA) over the last 10 years. The current price to book ratio for XOMA as of October 22, 2021 is 2.39.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

XOMA Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 24.71 2.40
2021-06-30 34.00 $10.31 3.30
2021-03-31 40.81 $7.26 5.62
2020-12-31 44.13 $7.70 5.73
2020-09-30 18.84 $3.45 5.46
2020-06-30 19.76 $3.48 5.67
2020-03-31 20.35 $4.21 4.83
2019-12-31 27.30 $4.51 6.06
2019-09-30 19.71 $2.95 6.69
2019-06-30 14.86 $2.41 6.18
2019-03-31 12.38 $2.75 4.49
2018-12-31 12.65 $2.16 5.85
2018-09-30 17.57 $0.14 127.78
2018-06-30 20.88 $0.58 36.06
2018-03-31 20.23 $0.68 29.90
2017-12-31 35.60 $0.70 50.76
2017-09-30 19.65 $0.50 39.39
2017-06-30 6.99 $-3.83 -1.82
2017-03-31 7.11 $-4.11 -1.73
2016-12-31 4.22 $-7.72 -0.55
2016-09-30 9.18 $-5.17 -1.77
2016-06-30 11.03 $-3.39 -3.25
2016-03-31 15.46 $-1.25 -12.36
2015-12-31 26.60 $-0.39 -68.57
2015-09-30 15.00 $-4.91 -3.05
2015-06-30 77.60 $-5.30 -14.63
2015-03-31 72.80 $-2.29 -31.81
2014-12-31 71.80 $0.53 134.26
2014-09-30 84.20 $-3.38 -24.94
2014-06-30 91.80 $-1.42 -64.88
2014-03-31 104.20 $0.33 320.02
2013-12-31 134.60 $-0.76 -177.90
2013-09-30 89.80 $-2.92 -30.73
2013-06-30 72.60 $-4.06 -17.87
2013-03-31 69.80 $-0.22 -318.29
2012-12-31 48.00 $5.21 9.22
2012-09-30 73.80 $-5.95 -12.41
2012-06-30 59.60 $1.13 52.54
2012-03-31 55.40 $5.73 9.68
2011-12-31 23.00 $8.55 2.69
2011-09-30 35.00 $12.97 2.70
2011-06-30 47.00 $14.99 3.13
2011-03-31 55.80 $16.40 3.40
2010-12-31 102.60 $16.56 6.20
2010-09-30 61.00 $9.48 6.43
2010-06-30 124.20 $7.85 15.83
2010-03-31 171.33 $24.49 7.00
2009-12-31 209.64 $25.90 8.10
2009-09-30 243.00 $16.24 14.96
2009-06-30 246.00 $-33.37 -7.37
2009-03-31 159.00 $-48.23 -3.30
2008-12-31 186.00 $-67.03 -2.77
2008-09-30 630.00 $-112.51 -5.60
2008-06-30 507.00 $-69.09 -7.34
2008-03-31 777.00 $-27.66 -28.10
2007-12-31 1017.00 $0.72 1407.42
2007-09-30 1023.00 $21.04 48.62
2007-06-30 912.00 $-31.34 -29.10
2007-03-31 867.00 $-13.49 -64.28
2006-12-31 660.00 $-108.54 -6.08
2006-09-30 567.00 $-116.47 -4.87
2006-06-30 510.00 $-84.75 -6.02
2006-03-31 687.00 $-79.48 -8.64
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.280B $0.029B
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1? with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76